Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Paraoxonase-2 (PON2) protects oral squamous cell cancer cells against irradiation-induced apoptosis
Prostate Cancer and Prostatic Diseases
Potential conflict of interest to note: Several of the study authors worked for the company who produced the product used in the study
Researchers should consult the complete peptide reconstitution guide and peptide storage guide for detailed protocols
56 weeks max with breaks Injection Site: Subcutaneous preferred for consistent delivery Goal Phases: Recomp, injury recovery, performance support Example Cycle (4 Weeks): Weeks 14: 15 mcg IGF-1 LR3 post-workout, 5x/week Paired with: Swolverine ZMT for hormone and sleep support, Collagen, and clean carb/protein intake Stack potential: MK-677 (low dose), or run as a solo peptide for clean recovery Both men and women should avoid exceeding 8 weeks of continuous IGF-1 LR3 use without taking a break, as prolonged elevation may increase insulin desensitization or desensitize receptors
Human Recombinant IGF-I LR3, ACF has a predicted molecular mass of 9 kDa
